Weaver Consulting Group’s Opko Health OPK Stock Holding History

Weaver Consulting Group’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-125	Closed	–	–	988
2020 Q1	$0	Hold	125	–	–	﹤0.01%	923
2019 Q4	$0	Hold	125	–	–	﹤0.01%	857
2019 Q3	$0	Hold	125	–	–	﹤0.01%	842
2019 Q2	$0	Buy	+125	New	+$273	﹤0.01%	847

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Weaver Consulting Group's OPK Position: Q2 2020 in Review

Weaver Consulting Group sold out of Opko Health (OPK) in Q2 2020, closing a stake of 125 shares.

Weaver Consulting Group first reported a position in OPK in Q2 2019 and held it in 4 quarters. The position peaked at $0 in Q1 2020. 210 funds tracked by Wall St. Rank hold OPK as of Q2 2020.

Weaver Consulting Group reported no remaining Opko Health position as of Q2 2020 after selling out during the quarter.
Weaver Consulting Group sold 125 Opko Health shares in Q2 2020.
Weaver Consulting Group first reported a position in Opko Health in Q2 2019 and held it in 4 quarters.
Weaver Consulting Group's Opko Health position peaked at $0 in Q1 2020.
210 funds tracked by Wall St. Rank held Opko Health as of Q2 2020.

Based on Weaver Consulting Group's 13F filing for Q2 2020, filed 24 Jul 2020.